AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 43 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $38,132,000,000 | +26.8% | 25,700,000 | +13.2% | 0.66% | +27.7% |
| Q3 2014 | $30,065,000,000 | +177.7% | 22,700,000 | +127.0% | 0.52% | +143.7% |
| Q2 2014 | $10,827,000,000 | +876.3% | 10,000,000 | +900.0% | 0.21% | +965.0% |
| Q4 2013 | $1,109,000,000 | -93.5% | 1,000,000 | -93.9% | 0.02% | -94.4% |
| Q3 2013 | $17,126,000,000 | +61.2% | 16,500,000 | +50.0% | 0.36% | +78.9% |
| Q2 2013 | $10,627,000,000 | – | 11,000,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 22,144 | $24,659,000 | 1.74% |
| Baker Brothers Advisors | 87,090,000 | $96,343,000 | 1.36% |
| SYMPHONY ASSET MANAGEMENT LLC | 10,000,000 | $11,063,000 | 0.81% |
| WOLVERINE ASSET MANAGEMENT LLC | 35,608,000 | $39,670,000 | 0.78% |
| Pinnacle Holdings, LLC | 2,110,000 | $2,337,374,000 | 0.68% |
| Man Investments (CH) AG | 1,200,000 | $1,337,000 | 0.55% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,969,000 | $32,352,000 | 0.41% |
| Visium Asset Management, LP | 13,000,000 | $14,461,000 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 7,380,000 | $8,240,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $2,771,000 | 0.14% |